Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
45 participants
INTERVENTIONAL
2026-01-14
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Vision in TBI
NCT01214070
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
NCT06105892
Novel Amblyopia Treatment With Virtual Reality Games
NCT06049459
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT05085210
Motor Performance Improvement After Visual Rehabilitation
NCT06698172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Intervention block followed by non-intervention block
Virtual-reality convergence training game
The participant plays a custom virtual-reality game that is designed to train convergence.
Group B
Non-intervention block followed by intervention block
Virtual-reality convergence training game
The participant plays a custom virtual-reality game that is designed to train convergence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual-reality convergence training game
The participant plays a custom virtual-reality game that is designed to train convergence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Place of residence within driving distance of Cleveland, OH
* Clinical eye exam within 6 months prior to enrollment and since the most recent TBI (if applicable) and the onset of near vision symptoms (if applicable)
* Best-corrected visual acuity 20/25 or better in each eye
* Convergence insufficiency (VR-NPC \< 32 deg)
Exclusion Criteria
* History of strabismus, amblyopia, or other binocular vision issues prior to TBI
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark F. Walker, MD
Role: PRINCIPAL_INVESTIGATOR
Louis Stokes VA Medical Center, Cleveland, OH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N5317-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.